BEDU-ADDO FRANK 4
4 · PDS Biotechnology Corp · Filed Jun 17, 2021
Insider Transaction Report
Form 4
BEDU-ADDO FRANK
DirectorPresident/CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-06-15−53,174→ 0 totalExercise: $6.57Exp: 2021-07-27→ Common Stock (53,174 underlying) - Exercise/Conversion
Common Stock
2021-06-15$6.57/sh+53,174$349,353→ 673,681 total - Tax Payment
Common Stock
2021-06-15$12.86/sh−27,166$349,355→ 646,515 total
Footnotes (2)
- [F1]On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021.
- [F2]The Stock Option is fully vested in accordance with its terms.